Pharming Group N.V. EV - Enterprise Value 2011-2026 | PHAR

Annual EV - Enterprise Value Pharming Group N.V.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	5.94 B	892 M	57.2 M	72.5 M	147 M	99.3 M	33.8 M	25.9 M	26.4 M	24.5 M	25.9 M

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
5.94 B	24.5 M	668 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	3.33 B	$ 22.57	0.04 %	$ 3.74 B	USA
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Akebia Therapeutics AKBA	493 M	$ 1.41	-1.4 %	$ 363 M	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
BioNTech SE BNTX	-4.91 B	$ 91.98	-0.11 %	$ 27.2 B	Germany
Aytu BioScience AYTU	-15.2 M	$ 2.56	-3.76 %	$ 16.1 M	USA
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.85	-1.39 %	$ 9.26 B	Australia
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 20.87	2.3 %	$ 976 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Aquestive Therapeutics AQST	540 M	$ 4.17	-0.24 %	$ 446 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Arcutis Biotherapeutics ARQT	3.64 B	$ 24.57	-0.16 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Cabaletta Bio CABA	253 M	$ 3.17	2.59 %	$ 319 M	USA
Codiak BioSciences CDAK	281 M	-	-55.98 %	$ 2.15 M	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	9.99 M	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 2.93	-4.87 %	$ 6.38 B	Israel
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Celldex Therapeutics CLDX	2.07 B	$ 33.62	3.73 %	$ 2.23 B	USA
Concert Pharmaceuticals CNCE	14.7 M	-	-	$ 401 M	USA
Akari Therapeutics, Plc AKTX	79.3 B	$ 3.92	1.03 %	$ 264 B	Britain
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Celsion Corporation CLSN	-3.55 M	-	-6.63 %	$ 13.9 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA